ARCHIVES

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

This article is from The Cancer Letter archive.

Vol. 39 No. 28 | July 12, 2013

Download PDF Visit The Full Archive

Related Articles

Scientists Brief Writers On Progress In Cancer Research

April 18, 1975

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

November 12, 1982

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Payline For 1988 Would Be Around 160 With President’s Budget

January 16, 1987

NCI Halts Routine P01 Site Visits Due to Travel Cut

February 7, 1992

In Brief: Deadline June 1 For New ACS Prevention Awards; Money Available To Fund Five More

April 11, 1980